These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8891553)

  • 1. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).
    Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT
    Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Chatelain PG
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():79-81. PubMed ID: 8219482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy for 3 years: the OZGROW experience.
    Cowell CT; Dietsch S; Greenacre P
    J Paediatr Child Health; 1996 Apr; 32(2):86-93. PubMed ID: 8860379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
    Albanese A; Stanhope R
    Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies.
    de Zegher F; Albertsson-Wikland K; Wilton P; Chatelain P; Jonsson B; Löfström A; Butenandt O; Chaussain JL
    Acta Paediatr Suppl; 1996 Oct; 417():27-31. PubMed ID: 9055905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height.
    Ranke MB; Lindberg A
    Acta Paediatr Suppl; 1996 Oct; 417():18-26. PubMed ID: 9055904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation.
    Stanhope R; Ackland F; Hamill G; Clayton J; Jones J; Preece MA
    Acta Paediatr Scand Suppl; 1989; 349():47-52; discussion 53-4. PubMed ID: 2750531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome.
    Azcona C; Albanese A; Bareille P; Stanhope R
    Horm Res; 1998; 50(1):22-7. PubMed ID: 9691209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.